Glimepiride Metformin Hydrochloride Tablet

Product Description

Glimiford M1/2 that combines two potent antidiabetic agents, glimepiride and metformin hydrochloride, in a single tablet. Glimepiride, a sulfonylurea derivative, acts by stimulating insulin secretion from pancreatic beta cells, thereby lowering blood glucose levels. Metformin hydrochloride, a biguanide, works primarily by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues. This combination offers synergistic effects, effectively controlling blood sugar levels in patients with type 2 diabetes mellitus. Glimiford M1/2 tablets are formulated to provide convenient dosing and enhanced patient compliance. Each tablet contains a precise combination of glimepiride and metformin hydrochloride, ensuring optimal therapeutic efficacy with minimal adverse effects. The formulation undergoes rigorous quality control measures to ensure consistency and potency, meeting pharmaceutical standards for safety and efficacy. Glimiford M1/2 tablets represent a valuable treatment option for managing type 2 diabetes, offering patients a convenient and effective means of glycemic control.